Cita APA

V, M., RM, S., JL, D., E, J., M, S., X, P., . . . F, C. (2024). PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention.

Citación estilo Chicago

V, Marco-Benedí, et al. PCSK9 Inhibitors On the Management of Primary and Secondary Cardiovascular Prevention. 2024.

Cita MLA

V, Marco-Benedí, et al. PCSK9 Inhibitors On the Management of Primary and Secondary Cardiovascular Prevention. 2024.